Anthem Biosciences Prepares for a Big Market Debut

SEBI Green Light Secured: Anthem Biosciences has received regulatory approval from SEBI to float its much-anticipated ₹3,395 crore IPO.

Offer Breakdown: The IPO comprises a complete Offer for Sale (OFS) by existing shareholders — no fresh issue of shares.

Backed by Private Equity: Private equity firm True North, which owns around 65% of the company, will offload a major chunk of its holding in the OFS.

Big League Banker Line-Up: Leading financial institutions like Kotak Mahindra Capital, Citigroup, and Jefferies are managing the issue.

Biotech Boom Bet: Anthem is a key player in contract research and manufacturing services (CRAMS) — a fast-growing segment in India’s life sciences sector.

Healthy Financials: As of FY23, the company clocked ₹855 crore in revenue and ₹275 crore in profit, underlining its profitability and scale.

Source: https://www.livemint.com/market/stock-market-news/ipo-watch-anthem-biosciences-gets-sebi-nod-to-launch-rs-3-395-crore-ipo-11744188136892.html

Comments

Trade Unlisted (TU) is not a stock exchange or an online platform for buying or selling unlisted shares, luxury assets, or real estate. It is not regulated by SEBI, IRDAI, RERA, or any other authority. Our focus is to provide information on unlisted startup companies, luxury assets, and real estate. We do not offer investment advice, guarantees, or warranties regarding any asset class. Investing in unlisted equities or alternative assets is high-risk and suitable only for accredited high-net-worth individuals (HNIs) with a long-term investment horizon. There is a possibility of capital loss, and investors should conduct their own due diligence and consult financial advisors before making decisions.The information on this website is for general informational purposes only and should not be construed as personalized investment advice or a recommendation to buy or sell any asset class. Market trends and data interpretations are illustrative and may not reflect actual future performance. TU is neither a stock exchange nor intends to be recognized as one under the Securities Contracts (Regulation) Act, 1956. We are not authorized to solicit investments, and the securities or asset classes discussed are not traded on regulated exchanges. While we strive for accuracy and timeliness, we make no representations or warranties regarding the completeness or reliability of the information. Any reliance on such information is at the user's own risk, and TU does not accept liability for decisions made based on this website.